Which feature best distinguishes classical complement pathway activation from alternative pathway activation?

Explanation

## Distinguishing Classical from Alternative Complement Pathways ### Classical Pathway (CP) **Key Point:** The classical pathway is initiated by antigen-antibody complexes (IgG or IgM bound to antigen), which bind to C1q and trigger the cascade. - Requires **IgG or IgM** binding to antigen - C1q recognition of Fc region is the trigger - More specific and antibody-dependent - Activated in secondary immune responses ### Alternative Pathway (AP) **Key Point:** The alternative pathway is initiated by direct recognition of pathogen-associated molecular patterns (PAMPs) without antibody involvement. - Activated by **microbial polysaccharides, lipopolysaccharides (LPS), and other PAMPs** - Does NOT require antigen-antibody complexes - Activated by **properdin, Factor B, and Factor D** - First-line defense against pathogens - Constitutively active at low levels (tick-over mechanism) ### Comparison Table | Feature | Classical Pathway | Alternative Pathway | | --- | --- | --- | | **Initiator** | Antigen-antibody complex (IgG/IgM) | Microbial PAMPs, LPS, polysaccharides | | **First component** | C1q | C3 (spontaneous hydrolysis) | | **Requires antibody** | Yes | No | | **Speed of activation** | Slower (secondary response) | Faster (innate, immediate) | | **Amplification** | Moderate | Positive feedback loop (C3 amplification) | | **Properdin involvement** | No | Yes (stabilizes C3 convertase) | ### Why This Matters **Clinical Pearl:** Classical pathway deficiency (e.g., C1q deficiency) predisposes to **autoimmune diseases** (SLE) because immune complexes are not cleared efficiently. Alternative pathway deficiency (e.g., Factor H deficiency) predisposes to **recurrent bacterial infections** and hemolytic uremic syndrome (HUS). **High-Yield:** The alternative pathway is the **primary defense against encapsulated bacteria** (Neisseria, Streptococcus pneumoniae) and is why **asplenic patients and those with complement deficiencies are at risk** for meningococcal sepsis. ### Why Other Options Are Wrong - **Option B (Bypasses C3):** Both pathways converge at C3; neither bypasses it. The alternative pathway actually amplifies through C3. - **Option C (Microbial PAMPs):** This is a feature of the alternative pathway, not a distinguishing feature from classical (which is antibody-dependent). - **Option D (C3a and C5a):** Both pathways generate these anaphylatoxins; this is not discriminatory. [cite:Robbins 10e Ch 6]